Moneycontrol PRO
Open App
you are here: HomeNewsSputnik v
sputnik v
Jump to
  • Ensure Sputnik V recipients take its 2nd, precaution doses: Centre to states Jul 14, 2022 07:23 PM IST

    Ensure Sputnik V recipients take its 2nd, precaution doses: Centre to states

    In a letter to states and Union Territories, Union Health Secretary Rajesh Bhushan on Thursday said it has been observed that the uptake of precaution dose of Sputnik V is only 0.5 per cent of those due for it.

  • Panacea Biotec share price hits 5% upper circuit Mar 02, 2022 03:15 PM IST

    Panacea Biotec share price hits 5% upper circuit

    Panacea Biotec has the manufacturing rights of Sputnik V COVID-19 vaccine in India. Its share prices hit a high of Rs 198.50 on BSE.

  • Sputnik V’s India manufacturing in peril after sanctions on jab’s Russian marketer Mar 02, 2022 10:24 AM IST

    Sputnik V’s India manufacturing in peril after sanctions on jab’s Russian marketer

    Russian banks being barred from SWIFT adds to worries

  • DCGI gives nod to Sputnik Light vaccine in India, may be used as booster shot Feb 06, 2022 09:52 PM IST

    DCGI gives nod to Sputnik Light vaccine in India, may be used as booster shot

    The Russian COVID-19 vaccine Sputnik V has failed to take off in India despite being one of the first few vaccines approved and arrive but Sputnik Light, which is a single-dose vaccine, is expected to fare better, especially as it may be used as a booster shot.

  • Sputnik V COVID vaccine shows higher Omicron-specific antibodies than Pfizer: Study Jan 21, 2022 12:55 PM IST

    Sputnik V COVID vaccine shows higher Omicron-specific antibodies than Pfizer: Study

    The joint Russian-Italian study — funded by the Russian Direct Investment Fund which markets Sputnik V — compared the blood serum samples of people taken three to six months after the second dose of the two vaccines.

  • COVID-19 | Australia recognises Sputnik V vaccine for international travellers Jan 17, 2022 04:15 PM IST

    COVID-19 | Australia recognises Sputnik V vaccine for international travellers

    Australia says the Gamaleya Institute's two-dose jab is an “additional COVID-19 vaccine that would be recognised” but no such clearance has been given to single-dose Sputnik Light

  • Sputnik V provides 'strong' defence against Omicron variant: RDIF Dec 17, 2021 06:07 PM IST

    Sputnik V provides 'strong' defence against Omicron variant: RDIF

    When used as a booster shot, Russia's single-dose Sputnik Light helps develop a stronger antibody response against the Omicron variant, the study by the Gamaleya Institute developer was cited as saying.

  • WHO still reviewing Sputnik V vaccine, as Russia presses bid Oct 05, 2021 07:26 PM IST

    WHO still reviewing Sputnik V vaccine, as Russia presses bid

    The clarification comes after Russia’s Health Minister Mikhail Murashko in recent days reportedly said that administrative issues were among the main holdups in WHO’s decision-making process about whether to grant an emergency use listing to Sputnik V as it has for a half-dozen other vaccines.

  • Zydus Cadila proposes Rs 1900 for three-dose COVID vaccine; Govt negotiating to bring it down Oct 03, 2021 06:31 PM IST

    Zydus Cadila proposes Rs 1900 for three-dose COVID vaccine; Govt negotiating to bring it down

    .

  • Russia sees no hurdles for WHO approval of Sputnik V vaccine Oct 03, 2021 07:41 AM IST

    Russia sees no hurdles for WHO approval of Sputnik V vaccine

    The Sputnik V shot, widely used in Russia and approved for use in over 70 countries, is undergoing a review by the WHO and the European Medicines Agency (EMA). Their approval could open up new markets for the shot, especially in Europe.

  • Dr Reddy's gets DCGI nod to conduct phase 3 trial of Sputnik Light in India Sep 15, 2021 02:17 PM IST

    Dr Reddy's gets DCGI nod to conduct phase 3 trial of Sputnik Light in India

    According to RDIF, the single-dose Sputnik Light vaccine demonstrated 79.4 percent efficacy

  • How to identify fake COVID-19 vaccines? Centre issues guidelines Sep 05, 2021 04:40 PM IST

    How to identify fake COVID-19 vaccines? Centre issues guidelines

    The Union Health Ministry shared a list of parameters with the states and Union territories to identify the authentic versions of Covishield, Covaxin and Sputnik V vaccines.

  • Panacea Biotec inks pact to manufacture 25 million doses of Sputnik V vaccine Aug 05, 2021 03:25 PM IST

    Panacea Biotec inks pact to manufacture 25 million doses of Sputnik V vaccine

    As per the agreement, Panacea Biotec shall produce Sputnik V vaccine using the ready to fill drug substance manufactured by Generium in Russia, and then supply the entire quantity thereof to Dr Reddy's for distribution in India.

  • Dr Reddy’s: Growth story remains intact; margins key monitorable Jul 28, 2021 11:43 AM IST

    Dr Reddy’s: Growth story remains intact; margins key monitorable

    Dr Reddy's margins are likely to be weighed by recurring investments - digitization, brand building exercise & elevated R&D - in near to medium term

  • Decoding India’s 2021 vaccination challenge Jul 28, 2021 10:16 AM IST

    Decoding India’s 2021 vaccination challenge

    While the government aims to fully vaccinate 94 crore adults in the country by the end of December, it is possible that many do not turn up for the jabs given vaccine hesitancy.

  • COVID-19 Vaccine Tracker: Over 54.76 lakh doses administered in India on July 22 Jul 23, 2021 10:49 AM IST

    COVID-19 Vaccine Tracker: Over 54.76 lakh doses administered in India on July 22

    On the 188th day of the vaccination drive on July 22, a total of 54,76,423 lakh jabs were administered across the country.

  • Ideas For Profit | Gland Pharma: Steady earnings compounder; invest on dips Jul 22, 2021 07:18 PM IST

    Ideas For Profit | Gland Pharma: Steady earnings compounder; invest on dips

    Gland Pharma trades at 30x EV/Ebitda for FY23, which is largely in line with some of its peers such as Syngene and Divi's Lab. Though we believe success in complex injectables holds further re-rating potential, here’s why we remain constructive on this steady earnings compounder and believe investors can accumulate during market-wide gyrations.

  • Gland Pharma’s new product play for FY22 holds a lot of promise Jul 22, 2021 10:58 AM IST

    Gland Pharma’s new product play for FY22 holds a lot of promise

    While the US market is still expected to clock 18-20 per cent growth for Gland Pharma in FY22, the company’s foray into non-US markets would accelerate growth in the medium term

  • COVID-19 Vaccine Tracker: Over 22.77 lakh jabs administered in India on July 21 Jul 22, 2021 10:39 AM IST

    COVID-19 Vaccine Tracker: Over 22.77 lakh jabs administered in India on July 21

    On the 187th day of the vaccination drive on July 21, 22,77,679 lakh jabs were administered across the country.

  • COVID-19 vaccine tracker: Nearly 25 lakh jabs administered on July 14 Jul 15, 2021 09:55 AM IST

    COVID-19 vaccine tracker: Nearly 25 lakh jabs administered on July 14

    So far, 39,13,40,491 doses of COVID-19 vaccines have been administered in India, the health ministry said.

  • Single dose of Sputnik V COVID-19 vaccine triggers strong antibody response: Study Jul 14, 2021 01:21 PM IST

    Single dose of Sputnik V COVID-19 vaccine triggers strong antibody response: Study

    The researchers noted that evidence from other vaccines offers support for the one-shot approach.

  • COVID-19 vaccine | Serum Institute inks pact with RDIF to make Sputnik V, to begin first batch production in September Jul 13, 2021 01:31 PM IST

    COVID-19 vaccine | Serum Institute inks pact with RDIF to make Sputnik V, to begin first batch production in September

    Serum Institute and RDIF plan to produce over 300 million doses of the Sputnik V vaccine in India per year.

  • Sputnik V soft launched in over 50 cities in India: Dr Reddy's Jul 13, 2021 10:03 AM IST

    Sputnik V soft launched in over 50 cities in India: Dr Reddy's

    "Starting initially in Hyderabad today, the soft launch rollout of Sputnik V has scaled up speedily and reached cities and towns all over India- including but not limited to Hyderabad, Vizag, Bengaluru, Mumbai, Navi Mumbai, Kolkata, Delhi, NCR, Chennai, Miryalaguda, Vijayawada, Baddi, Kolhapur, Kochi, Raipur, Chandigarh, Pune, Nagpur, Nashik it said in the tweet.

  • Sputnik V second dose shortage to delay India's full rollout: Dr Reddy's Jul 12, 2021 07:06 PM IST

    Sputnik V second dose shortage to delay India's full rollout: Dr Reddy's

    Dr. Reddy's had received about 3 million first doses by June 1 and about 360,000 doses of the second by early this month, the company and the Indian government have said.

  • Zydus Cadila’s Sharvil Patel:  We will manufacture one crore doses per month initially Jul 10, 2021 01:21 PM IST

    Zydus Cadila’s Sharvil Patel: We will manufacture one crore doses per month initially

    Managing Director of Zydus Group Sharvil Patel says the company has invested Rs. 400-500 crore for the development of ZyCoV-D, the world’s first plasmid DNA vaccine for human use.

Sections
ISO 27001 - BSI Assurance Mark